USD 0.07
(0.43%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -514.02 Thousand USD | -739.7% |
2022 | 80.35 Thousand USD | 107.89% |
2021 | -1.01 Million USD | -101.25% |
2020 | -506.35 Thousand USD | -2428.5% |
2019 | 21.74 Thousand USD | 107.04% |
2018 | -308.71 Thousand USD | -3225.62% |
2017 | -9283.00 USD | -100.8% |
2016 | 1.15 Million USD | 325.55% |
2015 | 272.41 Thousand USD | 6.72% |
2014 | 255.26 Thousand USD | 247.82% |
2013 | -172.68 Thousand USD | 66.29% |
2012 | -512.19 Thousand USD | -432.59% |
2011 | -96.17 Thousand USD | 82.99% |
2010 | -565.48 Thousand USD | -312.23% |
2009 | 266.44 Thousand USD | -97.33% |
2008 | 9.99 Million USD | 1701.95% |
2007 | -623.66 Thousand USD | 59.23% |
2006 | -1.52 Million USD | 60.91% |
2005 | -3.91 Million USD | -102.41% |
2004 | -1.93 Million USD | -1792.16% |
2003 | 114.25 Thousand USD | 119.09% |
2002 | -598.48 Thousand USD | -150.1% |
2001 | -239.29 Thousand USD | 30.99% |
2000 | -346.74 Thousand USD | -86.0% |
1999 | -186.42 Thousand USD | 65.81% |
1998 | -545.3 Thousand USD | 17.13% |
1997 | -658.04 Thousand USD | -1318.46% |
1996 | 54 Thousand USD | -83.33% |
1995 | 323.93 Thousand USD | 223.93% |
1994 | 100 Thousand USD | 0.0% |
1993 | 100 Thousand USD | -91.67% |
1992 | 1.2 Million USD | 700.0% |
1991 | -200 Thousand USD | 71.43% |
1990 | -700 Thousand USD | -40.0% |
1989 | -500 Thousand USD | 16.67% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 Q1 | -122.26 Thousand USD | -203.9% |
2023 Q3 | -199.97 Thousand USD | -83.52% |
2023 Q4 | -82.83 Thousand USD | 58.58% |
2023 FY | - USD | -739.7% |
2023 Q2 | -108.96 Thousand USD | 10.88% |
2022 Q1 | -94.61 Thousand USD | 75.66% |
2022 FY | - USD | 107.89% |
2022 Q4 | 117.67 Thousand USD | -5.6% |
2022 Q2 | -12.9 Thousand USD | 86.36% |
2022 Q3 | 124.65 Thousand USD | 1065.89% |
2021 Q1 | -303.88 Thousand USD | -376.53% |
2021 FY | - USD | -101.25% |
2021 Q2 | -12.92 Thousand USD | 95.75% |
2021 Q4 | -388.7 Thousand USD | 25.65% |
2021 Q3 | -522.8 Thousand USD | -3946.19% |
2020 Q1 | 13.01 Thousand USD | 126.06% |
2020 FY | - USD | -2428.5% |
2020 Q2 | -158.96 Thousand USD | -1321.5% |
2020 Q3 | 20.26 Thousand USD | 112.75% |
2020 Q4 | -63.77 Thousand USD | -414.64% |
2019 Q4 | -49.94 Thousand USD | -81.74% |
2019 Q2 | 86.16 Thousand USD | 135.61% |
2019 Q3 | -27.48 Thousand USD | -131.9% |
2019 Q1 | -241.96 Thousand USD | -18.99% |
2019 FY | - USD | 107.04% |
2018 Q1 | -445.54 Thousand USD | -1560.95% |
2018 Q2 | 33.16 Thousand USD | 107.44% |
2018 Q3 | 103.43 Thousand USD | 211.91% |
2018 Q4 | -203.35 Thousand USD | -296.59% |
2018 FY | - USD | -3225.62% |
2017 Q4 | 30.49 Thousand USD | -86.44% |
2017 Q2 | 180.83 Thousand USD | -24.17% |
2017 Q3 | 224.93 Thousand USD | 24.39% |
2017 Q1 | 238.46 Thousand USD | 782.19% |
2017 FY | - USD | -100.8% |
2016 Q2 | 524.15 Thousand USD | 1055.73% |
2016 FY | - USD | 325.55% |
2016 Q1 | -54.84 Thousand USD | -123.0% |
2016 Q4 | -34.95 Thousand USD | -108.1% |
2016 Q3 | 431.58 Thousand USD | -17.66% |
2015 Q4 | 238.45 Thousand USD | 168.75% |
2015 Q2 | 435.66 Thousand USD | 419.69% |
2015 FY | - USD | 6.72% |
2015 Q1 | 83.83 Thousand USD | -27.9% |
2015 Q3 | -346.86 Thousand USD | -179.62% |
2014 Q3 | 131.52 Thousand USD | 242.31% |
2014 FY | - USD | 247.82% |
2014 Q1 | -98.42 Thousand USD | -376.38% |
2014 Q2 | 38.42 Thousand USD | 139.04% |
2014 Q4 | 116.26 Thousand USD | -11.6% |
2013 Q1 | -238.68 Thousand USD | -28.3% |
2013 Q2 | -61.04 Thousand USD | 74.43% |
2013 FY | - USD | 66.29% |
2013 Q4 | 35.61 Thousand USD | 172.92% |
2013 Q3 | -48.83 Thousand USD | 20.0% |
2012 FY | - USD | -432.59% |
2012 Q4 | -186.03 Thousand USD | -124.31% |
2012 Q3 | -82.93 Thousand USD | -1729.65% |
2012 Q2 | -4533.00 USD | 93.97% |
2012 Q1 | -75.12 Thousand USD | -232.85% |
2011 Q2 | -40.25 Thousand USD | 81.01% |
2011 Q1 | -211.97 Thousand USD | -114.33% |
2011 Q3 | 41.77 Thousand USD | 203.77% |
2011 Q4 | -22.56 Thousand USD | -154.03% |
2011 FY | - USD | 82.99% |
2010 FY | - USD | -312.23% |
2010 Q4 | -98.89 Thousand USD | 48.19% |
2010 Q3 | -190.88 Thousand USD | -199.53% |
2010 Q1 | -183.17 Thousand USD | -95.04% |
2010 Q2 | -63.72 Thousand USD | 65.21% |
2009 Q2 | 648.49 Thousand USD | 5651.71% |
2009 FY | - USD | -97.33% |
2009 Q4 | -93.91 Thousand USD | 10.52% |
2009 Q3 | -104.96 Thousand USD | -116.19% |
2009 Q1 | -11.68 Thousand USD | -102.62% |
2008 FY | - USD | 1701.95% |
2008 Q1 | -281.27 Thousand USD | -121.91% |
2008 Q2 | -85.42 Thousand USD | 69.63% |
2008 Q3 | 4.34 Million USD | 5184.96% |
2008 Q4 | 446.4 Thousand USD | -89.72% |
2007 Q1 | -136.21 Thousand USD | -114.37% |
2007 Q2 | -124.96 Thousand USD | 8.26% |
2007 FY | - USD | 59.23% |
2007 Q3 | -90.67 Thousand USD | 27.44% |
2007 Q4 | -126.75 Thousand USD | -39.79% |
2006 Q3 | -1.79 Million USD | -231.04% |
2006 Q1 | 87.07 Thousand USD | 107.01% |
2006 Q4 | 948.03 Thousand USD | 152.72% |
2006 FY | - USD | 60.91% |
2006 Q2 | -543.23 Thousand USD | -723.89% |
2005 Q2 | -1.05 Million USD | -31.49% |
2005 Q1 | -805.8 Thousand USD | -27.61% |
2005 Q3 | -862.86 Thousand USD | 18.56% |
2005 FY | - USD | -102.41% |
2005 Q4 | -1.24 Million USD | -44.03% |
2004 FY | - USD | -1792.16% |
2004 Q2 | 57.15 Thousand USD | -47.71% |
2004 Q4 | -631.47 Thousand USD | -38.1% |
2004 Q3 | -457.27 Thousand USD | -900.09% |
2004 Q1 | 109.29 Thousand USD | 453.46% |
2003 Q4 | 19.74 Thousand USD | 172.93% |
2003 Q3 | -27.07 Thousand USD | 32.25% |
2003 Q2 | -39.96 Thousand USD | 88.07% |
2003 FY | - USD | 119.09% |
2003 Q1 | -335.03 Thousand USD | -882.84% |
2002 FY | - USD | -150.1% |
2002 Q1 | -162.49 Thousand USD | -209.61% |
2002 Q2 | -27.83 Thousand USD | 82.87% |
2002 Q3 | -136.45 Thousand USD | -390.27% |
2002 Q4 | -34.08 Thousand USD | 75.02% |
2001 Q2 | -117.14 Thousand USD | -5.89% |
2001 Q3 | -105.84 Thousand USD | 9.64% |
2001 FY | - USD | 30.99% |
2001 Q4 | 148.24 Thousand USD | 240.06% |
2001 Q1 | -110.63 Thousand USD | 25.85% |
2000 Q2 | 5461.00 USD | 114.13% |
2000 Q4 | -149.19 Thousand USD | -61.52% |
2000 Q3 | -92.37 Thousand USD | -1791.5% |
2000 FY | - USD | -86.0% |
2000 Q1 | -38.65 Thousand USD | 76.06% |
1999 Q4 | -161.42 Thousand USD | -85.26% |
1999 Q1 | -45.3 Thousand USD | 77.35% |
1999 FY | - USD | 65.81% |
1999 Q3 | -87.13 Thousand USD | -200.25% |
1999 Q2 | 86.91 Thousand USD | 291.87% |
1998 Q3 | -100 Thousand USD | 0.0% |
1998 FY | - USD | 17.13% |
1998 Q1 | -422.77 Thousand USD | 0.0% |
1998 Q2 | -100 Thousand USD | 76.35% |
1998 Q4 | -200 Thousand USD | -100.0% |
1997 Q1 | 254 Thousand USD | 0.0% |
1997 Q3 | -100 Thousand USD | 0.0% |
1997 FY | - USD | -1318.46% |
1997 Q2 | -100 Thousand USD | -139.37% |
1997 Q4 | - USD | 100.0% |
1996 Q3 | 100 Thousand USD | 0.0% |
1996 Q1 | 23.93 Thousand USD | -76.07% |
1996 FY | - USD | -83.33% |
1996 Q2 | 100 Thousand USD | 317.82% |
1996 Q4 | - USD | -100.0% |
1995 Q4 | 100 Thousand USD | -50.0% |
1995 Q3 | 200 Thousand USD | 100.0% |
1995 Q2 | 100 Thousand USD | 109.09% |
1995 Q1 | -1.1 Million USD | -375.0% |
1995 FY | - USD | 223.93% |
1994 Q4 | 400 Thousand USD | 500.0% |
1994 Q3 | -100 Thousand USD | -200.0% |
1994 Q1 | - USD | 100.0% |
1994 FY | - USD | 0.0% |
1994 Q2 | 100 Thousand USD | 0.0% |
1993 FY | - USD | -91.67% |
1993 Q2 | -100 Thousand USD | 66.67% |
1993 Q3 | 100 Thousand USD | 200.0% |
1993 Q4 | -100 Thousand USD | -200.0% |
1993 Q1 | -300 Thousand USD | -200.0% |
1992 Q3 | -100 Thousand USD | -108.33% |
1992 FY | - USD | 700.0% |
1992 Q4 | -100 Thousand USD | 0.0% |
1992 Q1 | -200 Thousand USD | -300.0% |
1992 Q2 | 1.2 Million USD | 700.0% |
1991 Q4 | 100 Thousand USD | 200.0% |
1991 Q1 | -1.4 Million USD | -800.0% |
1991 Q2 | -100 Thousand USD | 92.86% |
1991 Q3 | -100 Thousand USD | 0.0% |
1991 FY | - USD | 71.43% |
1990 Q2 | 300 Thousand USD | 127.27% |
1990 Q1 | -1.1 Million USD | -650.0% |
1990 Q3 | -100 Thousand USD | -133.33% |
1990 Q4 | 200 Thousand USD | 300.0% |
1990 FY | - USD | -40.0% |
1989 Q4 | 200 Thousand USD | 0.0% |
1989 FY | - USD | 16.67% |
1989 Q3 | 200 Thousand USD | 0.0% |
1989 Q2 | 200 Thousand USD | 120.0% |
1989 Q1 | -1 Million USD | -600.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
CVR Medical Corp. | - USD | Infinity% |
BioElectronics Corporation | -274.29 Thousand USD | -87.402% |
IR-Med Inc. | -4.89 Million USD | 89.493% |
Polarean Imaging plc | -11.19 Million USD | 95.408% |
Medical Supply International USA, Inc. | 456.06 Thousand USD | 212.71% |
Avitar, Inc. | -1.66 Million USD | 69.18% |
AVITA Medical, Inc. | -39.56 Million USD | 98.701% |
Manhattan Scientifics, Inc. | -1.16 Million USD | 55.84% |
Össur hf. | 137.38 Million USD | 100.374% |
Zecotek Photonics Inc. | -3.44 Million USD | 85.067% |
QHSLab, Inc. | -91.29 Thousand USD | -463.05% |
Wellstar International, Inc. | -1.35 Million USD | 62.107% |
Össur hf. | 137.38 Million USD | 100.374% |
Bionovate Technologies Corp | - USD | Infinity% |
EKF Diagnostics Holdings plc | 9.77 Million USD | 105.259% |
Escalon Medical Corp. | -58.46 Thousand USD | -779.261% |
Aurora Spine Corporation | -454.37 Thousand USD | -13.127% |
BrainsWay Ltd. | -2.31 Million USD | 77.757% |
Lattice Biologics Ltd. | - USD | Infinity% |
NewCardio, Inc. | -9.37 Million USD | 94.52% |
Hamilton Thorne Ltd. | 5.52 Million USD | 109.309% |
Vivos Inc. | -2.79 Million USD | 81.597% |
MicroPort Scientific Corporation | -347.57 Million USD | 99.852% |
Kelyniam Global, Inc. | -197.69 Thousand USD | -160.014% |
REMSleep Holdings, Inc. | -1.66 Million USD | 69.193% |
CYduct Diagnostics, Inc. | -378.9 Thousand USD | -35.66% |
Nanomix Corporation | -8.13 Million USD | 93.685% |
Theraclion SA | -2.05 Million USD | 74.935% |
Lifeline Biotechnologies, Inc. | - USD | Infinity% |
Wellness Center USA, Inc. | -707.03 Thousand USD | 27.298% |
Positron Corporation | -1.45 Million USD | 64.603% |
Rafina Innovations Inc. | - USD | Infinity% |
Electromedical Technologies, Inc. | -1.72 Million USD | 70.148% |
Lombard Medical, Inc. | -28.06 Million USD | 98.169% |
ALR Technologies Inc. | -6.4 Million USD | 91.969% |
Stratec SE | 39.91 Million USD | 101.288% |
Vycor Medical, Inc. | 100.94 Thousand USD | 609.223% |
Heart Tronics, Inc. | -14.85 Million USD | 96.54% |
Nu-Med Plus, Inc. | -118.25 Thousand USD | -334.66% |
Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 96.128% |
SANUWAVE Health, Inc. | -9.15 Million USD | 94.383% |
VMS Rehab Systems, Inc. | -68.55 USD | -749754.121% |
Guided Therapeutics, Inc. | -3.12 Million USD | 83.556% |
Ingen Technologies, Inc. | -8639.00 USD | -5850.052% |
Odyssey Group International, Inc. | -2.13 Million USD | 75.959% |
United American Healthcare Corporation | -59 Thousand USD | -771.229% |
ECGI Holdings, Inc. | -2.99 Million USD | 82.811% |
Capital Group Holdings, Inc. | -629.18 Thousand USD | 18.303% |
Urologix, Inc. | -6.34 Million USD | 91.897% |
Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | 58.525% |
Nexeon MedSystems Inc. | -765.96 Thousand USD | 32.892% |
SS Innovations International, Inc. | -20.37 Million USD | 97.477% |
Qualis Innovations, Inc. | -222.81 Thousand USD | -130.693% |
Smith & Nephew plc | 1 Billion USD | 100.051% |
NIOX Group Plc | 11.07 Million USD | 104.641% |
Fuse Medical, Inc. | 1.83 Million USD | 128.007% |
Broncus Holding Corporation | -25.19 Million USD | 97.96% |
Brain Scientific Inc. | -7.93 Million USD | 93.521% |
Pressure BioSciences, Inc. | -9.39 Million USD | 94.526% |
Health Logic Interactive Inc. | -18.4 Thousand USD | -2693.614% |